Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice

Compared to taxanes and epothilones, the two major classes of antimitotic drugs used in cancer treatment, a new FDA approved antitubulin drug may cause far less debilitating nerve damage in cancer survivors.